Form 4: VYNE Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Tyler Zeronda, a Director of VYNE Therapeutics Inc., received 185,798 shares of common stock on July 27, 2026.
Summary
- Grant/award: acquired 185,798 Stock Option (Right to Buy) on July 27, 2026; holds 185,798 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Tyler Zeronda — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Grant/award | Stock Option (Right to Buy) | 185,798 | — | — | 185,798 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Grant/award (185,798 shares) |
Keywords
insider transaction, Form 4, YARW, Yarrow Bioscience, Inc., neutral, Tyler Zeronda
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.